Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus enoxaparin in patients undergoing cerebral aneurysm surgery
IRCT20251213068305N1Phase 3Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of aspirin and enoxaparin in brain aneurysm (IA) and subarachnoid hemorrhage (SAH) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Vasospasm, Cerebral infarction and 4 more. Started Feb 2026; status: recruiting.
02
Drugs
aspirinenoxaparin
03
Conditions
brain aneurysm (IA)subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on IRCT20251213068305N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251213068305N1.